C07K

Watch

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
RE47194 Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates Apr 07, 15 Jan 08, 19 , Genentech, Inc.

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2019/0016,785 ANTIBODIES THAT POTENTLY NEUTRALIZE HEPATITIS B VIRUS AND USES THEREOF Oct 07, 16 Jan 17, 19 , Not available
2019/0016,803 DUAL SPECIFICITY POLYPEPTIDE MOLECULE Jul 13, 18 Jan 17, 19 , Not available
2019/0016,781 POLYNUCLEOTIDES ENCODING IMMUNE MODULATING POLYPEPTIDES Jun 15, 18 Jan 17, 19 , Not available
2019/0017,040 Compounds and Methods for Stabilizing Thrombin Activity Sep 27, 18 Jan 17, 19 , Not available
2019/0015,476 RECONSTITUTED HDL FORMULATION Feb 12, 18 Jan 17, 19 , CSL Limited
2019/0016,814 ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF May 31, 18 Jan 17, 19 , CytomX Therapeutics, Inc.
2019/0016,784 MUTATED VON WILLEBRAND FACTOR Jan 06, 17 Jan 17, 19 , Not available
2019/0016,819 ANTI-CD20 COMBINATIONS FOR TREATING TUMORS Jan 06, 17 Jan 17, 19 , Not available
2019/0014,758 HUMANIZED MOUSE MODEL May 11, 18 Jan 17, 19 , Not available
2019/0016,797 IMMUNE-STIMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2, AND FUSION PROTEINS THEREOF Jan 11, 17 Jan 17, 19 , Novartis AG; Universit├Ąt Z├╝rich;
2019/0016,775 Immunogenic Compositions Jul 09, 18 Jan 17, 19 , Not available
2019/0016,811 ANTI-GARP PROTEIN AND USES THEREOF May 09, 18 Jan 17, 19 , Not available
2019/0017,066 HERBICIDE TOLERANCE GENES AND METHODS OF USE THEREOF Jun 22, 18 Jan 17, 19 , Not available
2019/0017,046 PREPARATION, MEMBER FOR PREPARATION, AND METHODS FOR MANUFACTURING THESE Sep 27, 18 Jan 17, 19 , FUJIFILM Corporation
2019/0016,796 COMBINATION THERAPY COMPRISING A SUPERAGONISTIC ANTIBODY AGAINST INTERLEUKIN-2 AND A CHECKPOINT BLOCKADE AGENT Jan 11, 17 Jan 17, 19 , Universitat Zurich
2019/0016,758 Potent Compstatin Analogs Jan 25, 18 Jan 17, 19 , The Trustees of the University of Pennsylvania
2019/0016,779 NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Sep 14, 18 Jan 17, 19 , Not available
2019/0018,014 PEPTIDES FOR TARGETING GASTRIC CANCER, AND MEDICAL USE TEHREOF Oct 02, 18 Jan 17, 19 , University of Ulsan Foundation for Industry Cooperation
2019/0016,762 LACTOBACILLUS ACIDOPHILUS SURFACE LAYER PROTEIN A (SLPA) AS A THERAPEUTIC AGENT FOR THE TREATMENT OF INFLAMMATORY DISEASES Oct 15, 15 Jan 17, 19 , Not available
2019/0017,062 NUCLEIC ACID SEQUENCES ENCODING TRANSCRIPTION FACTORS REGULATING ALKALOID BIOSYNTHESIS AND THEIR USE IN MODIFYING PLANT METABOLISM Oct 01, 18 Jan 17, 19 , 22nd Century Limited, LLC

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.